2024 Partners
CRISPR QC
Lead Partner
CRISPR QC leads the genomics frontier with its CRISPR Analytics Platform, driven by the proprietary CRISPR-Chip. This revolutionary technology offers real-time insights into CRISPR/Cas kinetics, enabling effective gene-editing. The platform's data provides researchers with unparalleled accuracy and reliability in evaluating CRISPR/Cas systems, optimizing efficiency, and advancing applications in therapeutics, agriculture, and beyond. In the fast-moving field of genomics, CRISPR QC provides indispensable data for informed gene-editing decisions.
Aldveron
Expertise Partner
Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from discovery research to clinical trials to commercial applications. These products are critical raw materials and key components in commercially available drugs and medical devices.
Aldevron is known for inventing the GMP-Source® quality system and for specializing in cGMP manufacturing, operating the world’s largest facility at its company headquarters in Fargo, North Dakota, with additional facilities in Madison, Wisconsin
Seqwell
Expertise Partner
seqWell creates scalable genomics technologies that simplify workflows and help scientists to unlock transformative discoveries with sequencing. seqWell technology is focused on a novel, next-generation transposase, TnX™, to drive the high-performance needs of tagmentation and advance NGS. seqWell offers a range of library prep products and fragmentation workflows that allow customers to quickly and easily achieve higher levels of sample multiplexing.
Avance Biosciences
Exhibition Partner
Avance Biosciences is a leading CRO/CTL providing GLP & GMP-compliant assay development, assay validation, and sample testing services to support biological drug development and manufacturing activities world-wide. Our customized cell and gene therapy assay solutions include: on/off target analysis of CRISPR edited genes by NGS assays, off target identification using Guide-seq, GMP sgRNA ID testing and mRNA ID testing, single cell NGS assays, and testing of DNA or mRNA in preclinical and clinical trial samples.
Broken String Biosciences
Event Partner
Broken String Biosciences is a genomics company established with the goal to advance the next generation of more precise, safe, and effective cell and gene therapies through its cutting-edge technology platforms. The Company’s core technology, INDUCE-seq™, is a Next Generation Sequencing (NGS)-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify off-target genetic edits, and evaluate the associated genetic outcomes. The platform technology provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs.
Sumitomo Chemical
Event Partner
Sumitomo Chemical is a leading provider of gRNA for therapeutic genome editing. At our brand-new, state-of-the-art cGMP facility in Japan, we deliver top-notch gRNA at unmatched purity levels - 100mer with 90% purity; 130mer with over 80% purity; 200mer and even longer gRNAs with world-class quality. Our standardized manufacturing method allows us to offer seamless scale up from lab to plant, at short lead time.
Get in touch to explore how we can position your brand in front of 50+ Analytical Development, CMC & QC experts.
